(Q40927247)

24 September 2017

1 reference

title

Anti-tumoral effect of GM-CSF with or without cytokines and monoclonal antibodies in solid tumors (English)

1 reference

24 September 2017

P Ragnhammar

1

1 reference

24 September 2017

publication date

1 September 1996

1 reference

24 September 2017

1 reference

24 September 2017

volume

13

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

167-176

1 reference

Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity study

24 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02990844

Enhanced human lymphokine-activated killer cell function after brief exposure to granulocyte-macrophage-colony stimulating factor.

21 January 2018

1 reference

12 December 2020

Expression of c-fos protooncogene in normal human peripheral blood granulocytes

1 reference

12 December 2020

Antiproliferative and differentiative effect of granulocyte-macrophage colony-stimulating factor on a variant human small cell lung cancer cell line

1 reference

12 December 2020

Efficient selection of human tumor growth-inhibiting monoclonal antibodies

1 reference

12 December 2020

The therapeutic use of monoclonal antibodies in colorectal carcinoma

1 reference

12 December 2020

Cytotoxic functions of blood mononuclear cells in patients with colorectal carcinoma treated with mAb 17-1A and granulocyte/macrophage-colony-stimulating factor

1 reference

12 December 2020

Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor

1 reference

12 December 2020

A phase II trial of concomitant interferon-alpha-2b and granulocyte-macrophage colony-stimulating factor in patients with advanced renal cell carcinoma

1 reference

12 December 2020

Recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy: a phase Ib trial

1 reference

12 December 2020

Effect of monoclonal antibody 17-1A and GM-CSF in patients with advanced colorectal carcinoma--long-lasting, complete remissions can be induced

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor inhibits tumor growth during the postoperative period

1 reference

12 December 2020

Alterations in phenotype and cell‐surface antigen expression levels of human monocytes: Differential response to in vivo administration of rhm‐csf or rhgm‐csf

1 reference

12 December 2020

Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants

1 reference

12 December 2020

Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor

1 reference

12 December 2020

The human gene encoding GM-CSF is at 5q21-q32, the chromosome region deleted in the 5q- anomaly

1 reference

12 December 2020

Cytotoxicity of white blood cells activated by granulocyte-colony-stimulating factor, granulocyte/macrophage-colony-stimulating factor and macrophage-colony-stimulating factor against tumor cells in the presence of various monoclonal antibodies

1 reference

12 December 2020

The macrophage as an effector cell

1 reference

12 December 2020

Effects of human colony-stimulating factor on the uptake and destruction of a pathogenic parasite (Trypanosoma cruzi) by human neutrophils.

1 reference

12 December 2020

Heterocytolysis by macrophages activated by bacillus Calmette-Guérin: lysosome exocytosis into tumor cells.

1 reference

12 December 2020

Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self

1 reference

12 December 2020

Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB study

1 reference

12 December 2020

Cytokine effects and role of adhesive proteins and Fc receptors in human macrophage-mediated antibody dependent cellular cytotoxicity

1 reference

12 December 2020

Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma

1 reference

12 December 2020

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

12 December 2020

Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor

1 reference

12 December 2020

Intracellular hydroxyl radical production induced by recombinant human tumor necrosis factor and its implication in the killing of tumor cells in vitro

1 reference

12 December 2020

Granulocyte-monocyte-colony-stimulating factor augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity

1 reference

12 December 2020

Phase II trial of subcutaneously administered granulocyte-macrophage colony-stimulating factor in patients with metastatic renal cell carcinoma

1 reference

12 December 2020

Phase I trial of recombinant granulocyte-macrophage colony-stimulating factor in patients with lung cancer: clinical and immunologic effects

1 reference

12 December 2020

Structural homologies among the hemopoietins

1 reference

12 December 2020

Human recombinant granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes

1 reference

12 December 2020

Monocyte activation following systemic administration of granulocyte-macrophage colony-stimulating factor

1 reference

12 December 2020

Differential modulation of surface antigens on human macrophages by IFN-gamma and GM-CSF: effect on susceptibility to LAK lysis

1 reference

12 December 2020

Biosynthetic granulocyte-macrophage colony-stimulating factor enhances neutrophil cytotoxicity toward human leukemia cells

1 reference

12 December 2020

Purification and properties of colony-stimulating factor from mouse lung-conditioned medium

1 reference

12 December 2020

Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor.

1 reference

12 December 2020

Phase Ib trial of granulocyte-macrophage colony-stimulating factor combined with murine monoclonal antibody R24 in patients with metastatic melanoma

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor induces cytokine secretion by human polymorphonuclear leukocytes

1 reference

12 December 2020

Comparison of the effects of IL-3, granulocyte-macrophage colony-stimulating factor, and macrophage colony-stimulating factor in supporting monocyte differentiation in culture. Analysis of macrophage antibody-dependent cellular cytotoxicity

1 reference

12 December 2020

Evaluation of the antibody-dependent cytotoxic capabilities of individual human monocytes. Role of Fc gamma RI and Fc gamma RII and the effects of cytokines at the single cell level

1 reference

12 December 2020

Expression of IgG Fc receptors in myeloid leukemic cell lines. Effect of colony-stimulating factors and cytokines

1 reference

12 December 2020

Human recombinant granulocyte-macrophage colony-stimulating factor augments viability and cytotoxic activities of human monocyte-derived macrophages in long-term cultures

1 reference

12 December 2020

The human hematopoietic colony-stimulating factors

1 reference

12 December 2020

Granulocyte/macrophage colony-stimulating factor induces interleukin 1 production by human polymorphonuclear neutrophils

1 reference

12 December 2020

1 reference

12 December 2020

GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function

1 reference

12 December 2020

Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor

1 reference

12 December 2020

Interferon gamma and granulocyte/macrophage colony-stimulating factor inhibit growth and induce antigens characteristic of myeloid differentiation in small-cell lung cancer cell lines

1 reference

12 December 2020

Coinduction of granulocyte-macrophage colony-stimulating factor release and lymphokine-activated killer cell susceptibility in monocytes by interleukin-2 via interleukin-2 receptor beta.

1 reference

12 December 2020

Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha

1 reference

12 December 2020

Local peri-lesional therapy with rhGM-CSF for Kaposi's sarcoma

1 reference

12 December 2020

Recombinant human granulocyte/macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor alpha and interferon in cancer patients

1 reference

12 December 2020

Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.

1 reference

12 December 2020

Granulocyte-monocyte colony-stimulating-factor augments the interleukin-2-induced cytotoxic activity of human lymphocytes in the absence and presence of mouse or chimeric monoclonal antibodies (mAb 17-1A).

1 reference

12 December 2020

Amplification of IL-2-driven T cell proliferation by recombinant human IL-3 and granulocyte-macrophage colony-stimulating factor

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02990844

1 reference

Dimensions Publication ID

24 September 2017

1050476095

0 references

1 reference